Get started
Author

Erwin Woff

Observed names: E Woff, E. Woff, WOFF Erwin, Woff, Erwin
Observed institutions: Université Libre de Bruxelles, Inserm, Université Paris Sciences et Lettres, Institut Jules Bordet, Erasmus Hospital, Laboratoire d'imagerie translationnelle en oncologie, Institut Curie
ORCID: 0000-0001-9290-8929
Observed ORCID: 0000-0001-9290-8929
OpenAlex ID: A5087830871
Integration of clinical, pathological, radiological, and transcriptomic data improves prediction for first-line immunotherapy outcome in metastatic non-small cell lung cancer
2025 · Nicolas Captier, Marvin Lerousseau, et al. · Nature Communications · 67
PDF
Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as18F-FDG PET/CT–derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer
2018 · Erwin Woff, Alain Hendlisz, et al. · Journal of Nuclear Medicine · 23
PDF
Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer
2016 · Erwin Woff, Alain Hendlisz, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 23
PDF
Promising Candidate Prognostic Biomarkers in [ 18 F]FDG PET Images: Evaluation in Independent Cohorts of Non–Small Cell Lung Cancer Patients
2024 · Narinée Hovhannisyan-Baghdasarian, Marie Luporsi, et al. · Journal of Nuclear Medicine · 20
PDF
Combining 18F-FDG PET/CT–Based Metabolically Active Tumor Volume and Circulating Cell-Free DNA Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer
2019 · Erwin Woff, Pashalina Kehagias, et al. · Journal of Nuclear Medicine · 17
PDF
Successful (neo)adjuvant BRAF-targeted therapy in a patient with locally advanced BRAF V600E mutant melanoma
2015 · Teofila Seremet, Danielle Lienard, et al. · Melanoma Research · 13
Effects of β2-adrenergic stimulation on exercise capacity in normal subjects
2011 · S. P. Beloka, C. Janssen, et al. · European Journal of Applied Physiology · 13
Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated With Cabazitaxel
2023 · Qaid Ahmed Shagera, Ioannis Karfis, et al. · Clinical Nuclear Medicine · 11
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
2020 · Silvia Camera, Tugba Akin Telli, et al. · Cancers · 10
PDF
Development and External Validation of a PET Radiomic Model for Prognostication of Head and Neck Cancer
2023 · Wyanne A. Noortman, Nicolas Aide, et al. · Cancers · 9
PDF
Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer
2021 · Erwin Woff, Lisa Salvatore, et al. · Journal of Nuclear Medicine · 9
PDF
[177Lu]Lu-PSMA SPECT/CT for early response assessment using quantitative RECIP 1.0
2025 · Mutaz Kassas, Louise Devriendt, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 6
Incidental Detection of a Radiation-Induced Soft-Tissue Sarcoma on 68Ga-PSMA PET/CT in a Patient Previously Treated for Prostate Cancer
2019 · Nicolas Plouznikoff, Erwin Woff, et al. · Clinical Nuclear Medicine · 6
Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE
2023 · Wendy Delbart, Gwennaëlle Marin, et al. · Cancers · 5
PDF
Sarcoidosis Versus Lymphoma?
2021 · Lissandra Dal Lago, Julie Sarrand, et al. · European Journal of Case Reports in Internal Medicine · 5
PDF
Colon Adenocarcinoma Associated With Clostridium Septicum Endophthalmitis Detected on 18F-FDG PET/CT
2020 · Nicolas Plouznikoff, Carlos Artigas, et al. · Clinical Nuclear Medicine · 5
Imaging of tumour-induced osteomalacia using a gallium-68 labelled somatostatin analogue: Figure 1
2010 · Erwin Woff, Camilo Garcia, et al. · BMJ Case Reports · 2
Preoperative Assessment of Peritoneal Carcinomatosis with [ 68 Ga]Ga-FAPI-46 PET/CT: Agreement with Surgicopathologic PCI and Comparison with MRI and [ 18 F]FDG PET/CT
2026 · Ayça Arçay Öztürk, Gabriel Liberale, et al. · Journal of Nuclear Medicine · 1
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma
2025 · Wendy Delbart, Ioannis Karfis, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1
Development and Validation of an 18 F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography–Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer
2025 · Zelda Paquier, Jennifer Dhont, et al. · JCO Clinical Cancer Informatics · 1
Integration of clinical, pathological, radiological, and transcriptomic data improves the prediction of first-line immunotherapy outcome in metastatic non-small cell lung cancer
2024 · Nicolas Captier, Marvin Lerousseau, et al. · medRxiv · 1
PDF
Yttrium-90 Ibritumomab Tiuxetan Is Feasible and Efficient in Unselected Patients. Definitive Results of a Large Retrospective Phase IV Study
2015 · Valentine Richez, Julie Abraham, et al. · Blood · 1
Effect of neoadjuvant chemotherapy on [68Ga]Ga-FAPI-46 PET/CT in peritoneal carcinomatosis: a prospective translational exploratory sub-cohort analysis
2026 · Ayça Arçay Öztürk, Gabriel Liberale, et al. · European Journal of Nuclear Medicine and Molecular Imaging
Preoperative assessment of peritoneal carcinomatosis with [ 68 Ga]Ga-FAPI-46 PET/CT.
2026 · Ayca Arcay Ozturk, Gabriel Liberale, et al. · Journal of Clinical Oncology
Chronic Nonbacterial Osteomyelitis Evidenced by Concomitant [18F]FDG PET/CT and MRI in 2 Phases of the Disease
2025 · Hugues Azema, Anne-Leen Deleu, et al. · Clinical nuclear medicine open.
Works count: 49
Citation count: 249
H-index: 9
I10-index: 9
Year
Topic
Type